Pancreatic Cancer Research

ResearcherBC Cancer AgencyNo recent work listed

Hui‐Li Wong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3803-2107; OpenAlex author ID A5015015784. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: 4 papers · 2022: 2 papers

Papers 12

  1. Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma. Co-author DOI 10.1038/s41467-022-33718-7↗
  2. Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/ans.17787↗
  3. Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.3695↗
  4. Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.33304↗
  5. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2021.01.220↗
  6. Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics. Co-author DOI 10.1158/1078-0432.ccr-20-2831↗
  7. Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-1543↗
  8. Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer. First author DOI 10.1097/coc.0000000000000500↗
  9. Base excision repair deficiency signatures implicate germline and somatic MUTYH aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis. Co-author DOI 10.1101/mcs.a003681↗
  10. NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-19-0191↗
  11. Temporal Dynamics of Genomic Alterations in a BRCA1 Germline-Mutated Pancreatic Cancer With Low Genomic Instability Burden but Exceptional Response to Fluorour… Co-author DOI 10.1200/po.18.00057↗
  12. A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated w… Co-author DOI 10.1002/cjp2.75↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel John Renouf · 11 shared papers, 2017–2022 · strength 0.95
  2. David F. Schaeffer · 10 shared papers, 2017–2022 · strength 0.85
  3. Joanna M. Karasinska · 9 shared papers, 2017–2022 · strength 0.76
  4. Steve E. Kalloger · 8 shared papers, 2017–2022 · strength 0.69
  5. Janessa J. Laskin · 7 shared papers, 2018–2022 · strength 0.58
  6. James Thomas Topham · 6 shared papers, 2019–2022 · strength 0.57
  7. Jennifer Jane Knox · 5 shared papers, 2019–2022 · strength 0.43
  8. Steve Gallinger · 5 shared papers, 2019–2022 · strength 0.43
  9. Grainne Mary O'Kane · 4 shared papers, 2020–2022 · strength 0.37
  10. Faiyaz Notta · 4 shared papers, 2020–2022 · strength 0.37
  11. Michael K.C. Lee · 4 shared papers, 2019–2021 · strength 0.35
  12. Erica S. Tsang · 3 shared papers, 2019–2022 · strength 0.29
  13. Rachel Anne Goodwin · 2 shared papers, 2021–2022 · strength 0.20
  14. Oliver F. Bathe · 2 shared papers, 2021–2022 · strength 0.20
  15. Martin R. Jones · 3 shared papers, 2018–2019 · strength 0.19
  16. Alexander Grogan · 1 shared paper, 2022 · strength 0.16
  17. Benjamin P. T. Loveday · 1 shared paper, 2022 · strength 0.16
  18. Benjamin N. J. Thomson · 1 shared paper, 2022 · strength 0.16
  19. Hyun Soo Ko · 1 shared paper, 2022 · strength 0.16
  20. Peter Gibbs · 1 shared paper, 2022 · strength 0.16
  21. Belinda Lee · 1 shared paper, 2022 · strength 0.16
  22. Sharlene Gill · 2 shared papers, 2019 · strength 0.16
  23. Malcolm J. Moore · 2 shared papers, 2019–2020 · strength 0.15
  24. Kasmintan A. Schrader · 2 shared papers, 2018–2019 · strength 0.12
  25. Julia R. Naso · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.